ENDO: Increased Bone Density Following Two Years Of Growth Hormone Treatment In Men With Idiopathic Osteoporosis
Unregistered User
If this is not your name, click here.
Contact Us | Order Now | Journals | Bookstore | Register a colleague
 
  SEARCH  
News
Bookstore
Medline
The Web
Meetings & Congresses
Complete Doctor's Guide
 


 EXPLORE :
 news  All News
 webcasts All Webcasts
 All cases All Cases
 Meetings All Meetings & Congresses
 Medical All Medical Resources

top





New drugs / indications

English Dictionary

Medical Dictionary

Thesaurus



Warning | Privacy | Awards



 Favourite Journals 

Click here to choose your favourite journals


 Favourite Sites 

Click here to choose your favourite sites


 Languages 



  




ENDO: Increased Bone Density Following Two Years Of Growth Hormone Treatment In Men With Idiopathic Osteoporosis

By Amy Lazarus Yaroch
Special to DG News

DENVER, CO -- June 24, 2001 -- Growth Hormone (GH) treatment might be a new possible alternative therapy for men with idiopathic osteoporosis.

Dr. Peter Gillberg with University Hospital, in Uppsala, Sweden reported findings yesterday (June 23) at the 83rd Annual Meeting of the Endocrine Society (ENDO) in Denver, Colorado.

Although mostly affecting women, osteoporosis, a condition resulting in decreased mineralized bone mass, can also strike men. Idiopathic osteoporosis, which accounts for approximately 30 to 40 percent of osteoporosis found in men, is a condition of unknown cause. Patients usually present with fractures and lumbar spine pain.

The researchers evaluated 29 men, age 27-62 years with idiopathic osteoporosis who were assigned to either continuous (Group A) or intermittent (group B) treatment with rhGH (Genotropinâ, Pharmacia) for two years, with a one year follow-up.

At baseline and every six months, subjects had their bone mineral density, bone mineral content, and body composition measured by dual energy x-ray absorptiometry (DXA). At baseline and after two years, an x-ray was taken of the lumbar spine, according to researchers.

After two years, for Group A, bone mineral density increased 4.1 percent in the lumbar spine. For Group B, there was an increase of 3.4 percent, which was not significant. After another year of follow-up, the increase in bone mineral density was 4.6 percent and 6.6 percent for Groups A and B, respectively, with both values significant.

"Growth hormone can be a possible treatment option for patients with osteoporosis," Dr. Gillberg told Doctor’s Guide. He added cautionary note, "Growth hormone is not slated for use for osteoporosis. We need larger studies to see if there is any effect of GH on fracture risk of the patients."

Dr. Gillberg concluded, "Previous studies that we have conducted have shown that GH has an effect on bone formation. What we need now is further studies on growth hormone."

E-mail this page
to a friend or colleague!
To print,
use this version




Any question regarding a medical diagnosis, treatment, referral, drug availability or pricing should be directed to either a licensed physician or to the product's manufacturer.

If you have any technical questions or other concerns about this site, feel free to contact us at webmaster@docguide.com.

All contents Copyright (c) 1995- Doctor's Guide Publishing Limited. All rights reserved.


Employment opportunities | Partnering opportunities